Aberrant activation of JAK2 in MPN is associated with hyperproliferation of myeloid progenitor cells, abnormal inflammatory cytokine release as well as hyper-agglutination and thrombosis. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.